Literature DB >> 14764282

Cardiovascular risk associated with the metabolic syndrome.

Robert S Lindsay1, Barbara V Howard.   

Abstract

The term metabolic syndrome refers to a clustering of cardiovascular risk factors, most of which also share insulin resistance as an additional feature. Scientific effort has concentrated on understanding why these diverse cardiovascular risks co-occur in individuals and in determining the presumed common environmental or genetic factors that might underpin this. Clinically important developments include publication of standard definitions of the metabolic syndrome and recommendations for the use of type 2 diabetes and the presence of the metabolic syndrome as critical "risk stratifiers" in cardiovascular disease prevention. The remarkable recent secular increases in the prevalence of type 2 diabetes and obesity in many populations mean that the importance of the metabolic syndrome as a determinant of cardiovascular disease is likely to increase until these trends can be reversed.

Entities:  

Mesh:

Year:  2004        PMID: 14764282     DOI: 10.1007/s11892-004-0013-9

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  49 in total

1.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Saverio Parlongo; Lorenzo S Malatino; Graziella Bonanno; Giuseppe Seminara; Francesco Rapisarda; Pasquale Fatuzzo; Michele Buemi; Giacomo Nicocia; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

2.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

Review 3.  The role of TNFalpha and TNF receptors in obesity and insulin resistance.

Authors:  G S Hotamisligil
Journal:  J Intern Med       Date:  1999-06       Impact factor: 8.989

4.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

5.  Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.

Authors:  M I Schmidt; B B Duncan; A R Sharrett; G Lindberg; P J Savage; S Offenbacher; M I Azambuja; R P Tracy; G Heiss
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

6.  Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men.

Authors:  J Kuusisto; P Lempiäinen; L Mykkänen; M Laakso
Journal:  Diabetes Care       Date:  2001-09       Impact factor: 19.112

7.  Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.

Authors:  D B Savage; C P Sewter; E S Klenk; D G Segal; A Vidal-Puig; R V Considine; S O'Rahilly
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

8.  Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.

Authors:  Paul M Ridker; Nancy R Cook; Suzanne Cheng; Henry A Erlich; Klaus Lindpaintner; Jorge Plutzky; Robert Y L Zee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-27       Impact factor: 8.311

9.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

10.  Components of the "metabolic syndrome" and incidence of type 2 diabetes.

Authors:  Robert L Hanson; Giuseppina Imperatore; Peter H Bennett; William C Knowler
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

View more
  28 in total

1.  Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects.

Authors:  Reza Meshkani; Hamzeh Saberi; Narges MohammadTaghvaei; Mohammad Amin Tabatabaiefar
Journal:  Mol Cell Biochem       Date:  2011-08-12       Impact factor: 3.396

2.  Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls.

Authors:  Alison J Dawson; Thozhukat Sathyapalan; Peter Sedman; Ramzi Ajjan; Eric S Kilpatrick; Stephen L Atkin
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

3.  A pilot study of chromium picolinate for weight loss.

Authors:  Yuka Yazaki; Zubaida Faridi; Yingying Ma; Ather Ali; Veronika Northrup; Valentine Yanchou Njike; Lauren Liberti; David L Katz
Journal:  J Altern Complement Med       Date:  2010-03       Impact factor: 2.579

Review 4.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

5.  The metabolic syndrome in patients on peritoneal dialysis: prevalence and influence on cardiovascular morbidity.

Authors:  Senija Rasić; Almira Hadzović-Dzuvo; Damir Rebić; Snezana Uncanin; Azra Hadzić; Aida Mujaković; Indira Kulenović
Journal:  Bosn J Basic Med Sci       Date:  2010-04       Impact factor: 3.363

Review 6.  Genetic determinants of the metabolic syndrome.

Authors:  Michèle M Sale; Jonathan Woods; Barry I Freedman
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

7.  Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population.

Authors:  Masakazu Nagahori; Sea Bong Hyun; Teruji Totsuka; Ryuichi Okamoto; Erika Kuwahara; Toru Takebayashi; Makoto Naganuma; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2010-04-23       Impact factor: 7.527

8.  Standard and Novel Treatment Options for Metabolic Syndrome and Diabetes Mellitus.

Authors:  Elliott M Groves; Katherine Yu; Nathan D Wong; Shaista Malik
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-11-15

9.  Metabolic syndrome, obesity, and gastrointestinal cancer.

Authors:  Shintaro Fujihara; Hirohito Mori; Hideki Kobara; Noriko Nishiyama; Mitsuyoshi Kobayashi; Makoto Oryu; Tsutomu Masaki
Journal:  Gastroenterol Res Pract       Date:  2012-12-11       Impact factor: 2.260

10.  Educational Disparities in Distribution of Cardiovascular Risk Factors and Quality of Care in Korean Adults: Korean National Health and Nutrition Survey IV.

Authors:  Jae-Moon Yoon; Ji-Hye Kim; Beom-Seok Suh; Sang Min Park
Journal:  Korean J Fam Med       Date:  2013-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.